SIGLEC10 and glioblastoma: With the increased understanding of the mechanisms underlying cancer immunology in the glioblastoma, especially the role of the “don't eat me” CD47‐SIRPα signaling and CD24‐Siglec10 signaling, we propose here that the combined blockage of these two pathways may effectively activate the innate immune responses toward glioblastoma.